Skip to main content

Vir Biotechnology, Inc.

VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001706431

No open-market purchases or sales by Vir Biotechnology, Inc. insiders were filed in the last 90 days; 237 institutions reported holding it in 13F filings for Q2 2026, worth $1.49B in total; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in Vir Biotechnology, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
225
+9 vs. Q3 2022
Shares held
86.1M
−719.4K (−0.8%) vs. Q3 2022
Total value
$2.18B
+$504.8M (+30.2%) vs. Q3 2022
New holders
34
81 more added
Sold out
25
75 more reduced

5 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 225 institutions
Q1 2021: 157 institutionsQ2 2021: 166 institutionsQ3 2021: 175 institutionsQ4 2021: 210 institutionsQ1 2022: 204 institutionsQ2 2022: 214 institutionsQ3 2022: 221 institutionsQ4 2022: 225 institutionsQ1 2023: 234 institutionsQ2 2023: 227 institutionsQ3 2023: 215 institutionsQ4 2023: 207 institutionsQ1 2024: 210 institutionsQ2 2024: 215 institutionsQ3 2024: 197 institutionsQ4 2024: 208 institutionsQ1 2025: 234 institutionsQ2 2025: 213 institutionsQ3 2025: 213 institutionsQ4 2025: 218 institutionsQ1 2026: 252 institutionsQ2 2026: 237 institutions
Value heldQ4 2022: $2.18B
Q1 2021: $3.87BQ2 2021: $3.64BQ3 2021: $3.24BQ4 2021: $3.25BQ1 2022: $2.09BQ2 2022: $2.20BQ3 2022: $1.68BQ4 2022: $2.18BQ1 2023: $2.06BQ2 2023: $2.23BQ3 2023: $827.4MQ4 2023: $887.2MQ1 2024: $901.0MQ2 2024: $783.1MQ3 2024: $656.3MQ4 2024: $652.0MQ1 2025: $604.5MQ2 2025: $558.5MQ3 2025: $610.8MQ4 2025: $696.5MQ1 2026: $1.25BQ2 2026: $1.49B
Institutions holding VIR and their total value by quarter
QuarterHoldersValue
Q2 2026237$1.49B
Q1 2026252$1.25B
Q4 2025218$696.5M
Q3 2025213$610.8M
Q2 2025213$558.5M
Q1 2025234$604.5M
Q4 2024208$652.0M
Q3 2024197$656.3M
Q2 2024215$783.1M
Q1 2024210$901.0M
Q4 2023207$887.2M
Q3 2023215$827.4M
Q2 2023227$2.23B
Q1 2023234$2.06B
Q4 2022225$2.18B
Q3 2022221$1.68B
Q2 2022214$2.20B
Q1 2022204$2.09B
Q4 2021210$3.25B
Q3 2021175$3.24B
Q2 2021166$3.64B
Q1 2021157$3.87B

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Vir Biotechnology, Inc.; share changes are against Q3 2022.

Institutions holding VIR in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Price T Rowe Associates Inc385,648$9.76M0.00%+390.0%Added
Skandinaviska Enskilda Banken AB (publ)443,600$11.2M0.08%+443,600New
Principal Financial Group Inc488,864$12.4M0.01%+8,118+1.7%Added
Nuveen Asset Management, LLC493,722$12.5M0.00%−72,659−12.8%Reduced
Invesco Ltd.496,226$12.6M0.00%−9,720−1.9%Reduced
Bank of America Corp509,853$12.9M0.00%+73,763+16.9%Added
Goldman Sachs Group Inc617,157$15.6M0.00%−71,625−10.4%Reduced
Norges Bank728,560$18.4M0.00%+112,693+18.3%Added
Charles Schwab Investment Management Inc734,747$18.6M0.01%+83,374+12.8%Added
Northern Trust Corp778,699$19.7M0.00%−51,965−6.3%Reduced
Bank of New York Mellon Corp836,400$21.2M0.00%+106,313+14.6%Added
Avidity Partners Management LP850,000$21.5M0.50%+850,000New
American Century Companies Inc1,053,920$26.7M0.02%+493,599+88.1%Added
Renaissance Technologies LLC1,058,400$26.8M0.04%−454,094−30.0%Reduced
Pacer Advisors, Inc.1,099,394$27.8M0.14%+1,099,190+538,818.6%Added
Morgan Stanley1,177,828$29.8M0.00%+32,170+2.8%Added
Geode Capital Management, LLC1,466,278$37.1M0.01%+50,049+3.5%Added
Bill & Melinda Gates Foundation1,559,142$39.5M30.41%00.0%Unchanged
Alliancebernstein L.P.2,353,859$59.6M0.03%+19,541+0.8%Added
Baillie Gifford & Co3,984,601$100.9M0.11%+5,944+0.1%Added
State Street Corp5,476,457$138.6M0.01%−353,960−6.1%Reduced
Temasek Holdings (Private) Ltd5,710,510$144.5M0.84%−326,311−5.4%Reduced
Vanguard Group Inc10,094,501$255.5M0.01%+166,085+1.7%Added
BlackRock Inc.14,136,628$357.8M0.01%+262,902+1.9%Added
SB Investment Advisers (UK) Ltd20,259,535$512.8M4.28%−1,826,745−8.3%Reduced
Balyasny Asset Management LLC0$00.00%−385,146−100.0%Sold out
Twinbeech Capital LP0$00.00%−165,460−100.0%Sold out
University of Texas/Texas Am Investment Managment Co0$00.00%−130,409−100.0%Sold out
Vident Investment Advisory, LLC0$00.00%−84,414−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−54,496−100.0%Sold out
APG Asset Management N.V.0$00.00%−32,600−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−21,926−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−19,642−100.0%Sold out
Jacobs Levy Equity Management, Inc0$00.00%−19,169−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−18,600−100.0%Sold out
Verition Fund Management LLC0$00.00%−16,646−100.0%Sold out
NinePointTwo Capital0$00.00%−15,466−100.0%Sold out
Natixis0$00.00%−15,043−100.0%Sold out
Occudo Quantitative Strategies LP0$00.00%−14,815−100.0%Sold out
HSBC Holdings PLC0$00.00%−13,776−100.0%Sold out
Cambridge Investment Research Advisors, Inc.0$00.00%−11,426−100.0%Sold out
Handelsbanken Fonder AB0$00.00%−11,000−100.0%Sold out
LPL Financial LLC0$00.00%−10,859−100.0%Sold out
Cna Financial Corp0$00.00%−10,192−100.0%Sold out
Amundi0$00.00%−3,842−100.0%Sold out
Simplex Trading, LLC0$00.00%−4,082−100.0%Sold out
Macquarie Group Ltd0$00.00%−1,731−100.0%Sold out
Tiff Advisory Services Inc0$00.00%−831−100.0%Sold out
Massmutual Trust Co FSB0$00.00%−51−100.0%Sold out
Beaird Harris Wealth Management, LLC0$00.00%−28−100.0%Sold out
AGF Investments LLC––––Not filed
Agf Investments Inc.––––Not filed
Hightower 6M Holding, LLC––––Not filed
Wipfli Financial Advisors LLC,––––Not filed
American Portfolios Advisors––––Not filed